Biomedical Research, Science, & Technology

This is the PDF version of a Reference Paper prepared for the National Research Summit on Care, Services, and Supports for Persons with Dementia and Their Caregivers (also called the Research Summit on Dementia Care).

The objective of this project was to develop methods to measure the degree of interoperability as a result of data sharing and use between users of certified technologies who are eligible for Meaningful Use (MU) incentives and non-incentivized Trading Partners (TPs) using non-certified technologies.

LifeWorks is one of nine organizations selected to participate in the Teen Pregnancy Prevention Replication Study. The study is a rigorous five-year evaluation of replications of evidence-based interventions aimed at preventing teen pregnancy, sexually-transmitted infections (STIs), and other sexual risk behaviors.

This report provides an overview of current efforts for implementing electronic health information exchange (eHIE) by long-term and post-acute care (LTPAC) providers. The report describes the extent to which LTPAC providers are preparing for and implementing eHIE with their partners and assessing its impact.

In 2011, the U.S. federal government launched the Strong Cities, Strong Communities Initiative, a new model of federal-local collaboration designed to (i) improve how the federal government invests in cities, (ii) offer technical assistance to support local priorities, and (iii) help to coordinate funds at the local, state, and federal level.

In 2011, the U.S. federal government launched the Strong Cities, Strong Communities Initiative, a new model of federal-local collaboration designed to (i) improve how the federal government invests in cities, (ii) offer technical assistance to support local priorities, and (iii) help to coordinate funds at the local, state, and federal level.

Pharmaceutical companies conduct clinical trials for many reasons. The most obvious goal of clinical trials is to demonstrate safety and efficacy to gain Food and Drug Administration (FDA) approval. FDA provides guidance to developers about what constitutes acceptable clinical trials and appropriate outcomes.

This PDF was submitted as an attachment to a Public Comment sent to the Advisory Council on Alzheimer's Research, Care, and Services and/or the National Alzheimer's Project Act website.